Recurrent Childhood Acute Lymphoblastic Leukemia Terminated Phase 1 Trials for DB11870 (RG-4733)

IndicationStatusPhase
DBCOND0028597 (Recurrent Childhood Acute Lymphoblastic Leukemia)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01088763Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell LeukemiaTreatment